Bio Port Korea Inc. (KOSDAQ:188040)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,290.00
+90.00 (1.73%)
At close: Aug 11, 2026

Bio Port Korea Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Revenue
75,39770,88073,34668,699
Revenue Growth
5.00%-3.36%6.77%-
Gross Profit
18,97317,32020,93619,083
Operating Income
1,615830.055,2404,919
Net Income
-730.25-1,4034,1123,369
Earnings Per Share
-165.84-336.141438.991302.58
EPS Growth
--10.47%-

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '24 Dec '23
South Korea
42,00837,35642,815
Overseas
28,87235,99025,884
Total
70,88073,34668,699

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Cash & Investments
13,54819,16011,7637,546
Total Debt
11,23411,81014,42924,306
Net Cash (Debt)
2,3147,350-2,666-16,760
Net Cash Growth
----
Net Cash Per Share
525.441760.47-744.93-4732.22

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-382.274,74112,0742,022
Capital Expenditures
-4,446-2,254-3,584-3,275
Free Cash Flow
-4,8282,4868,491-1,253
Free Cash Flow Growth
--70.72%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Gross Margin
25.16%24.44%28.54%27.78%
Operating Margin
2.14%1.17%7.14%7.16%
Pretax Margin
-1.33%-2.61%7.30%5.23%
Profit Margin
-0.97%-1.98%5.61%4.91%
FCF Margin
-6.40%3.51%11.58%-1.82%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PE Ratio
--2.943.35
Forward PE
-4.57--
P/FCF Ratio
-14.931.42-
PS Ratio
0.320.520.170.16